HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers

PHASE4RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 10, 2022

Primary Completion Date

April 30, 2026

Study Completion Date

December 31, 2026

Conditions
Hepatitis B
Interventions
BIOLOGICAL

Hepatitis B Vaccine (Recombinant)

Hepatitis B Vaccine (Recombinant) 20 mcg intramuscular injection at 0-1-6 months

Trial Locations (1)

10065

RECRUITING

The Rockefeller University, New York

All Listed Sponsors
collaborator

Weill Medical College of Cornell University

OTHER

lead

Rockefeller University

OTHER